• Return to Headlines

Clovis Oncology Shares Down 64.9% Since SmarTrend's Sell Call (CLVS)

By Nick Russo

SmarTrend identified a Downtrend for Clovis Oncology (NASDAQ:CLVS) on July 25th, 2018 at $44.69. In approximately 4 months, Clovis Oncology has returned 64.89% as of today's recent price of $15.69.

In the past 52 weeks, Clovis Oncology share prices have been bracketed by a low of $11.50 and a high of $74.60 and are now at $15.69, 36% above that low price. Over the last five market days, the 200-day moving average (MA) has gone down 2.1% while the 50-day MA has declined 5.7%.

Clovis Oncology Inc. is a biopharmaceutical company. The Company is focused on acquiring, developing, and commercializing innovative anti-cancer agents in the United States, Europe and additional international markets. Clovis target its development programs for the treatment of specific subsets of cancer populations.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Clovis Oncology.

Log in and add Clovis Oncology (CLVS) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights clovis oncology

Ticker(s): CLVS